| Item Type | Name |
|
Concept
|
Aged, 80 and over
|
|
Concept
|
Aged
|
|
Concept
|
Middle Aged
|
|
Academic Article
|
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
|
|
Academic Article
|
Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis.
|
|
Academic Article
|
Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.
|
|
Academic Article
|
Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease.
|
|
Academic Article
|
Pharmacological therapy in progressive supranuclear palsy.
|
|
Academic Article
|
Neuropharmacology in the elderly.
|
|
Academic Article
|
Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease.
|
|
Academic Article
|
Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.
|
|
Academic Article
|
Association between antipsychotics and body mass index when treating patients with tics.
|
|
Academic Article
|
Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance.
|
|
Academic Article
|
I finally see what you see: Parkinson's disease visual hallucinations captured with functional neuroimaging.
|
|
Academic Article
|
Hemiparkinsonism with hemiatrophy.
|
|
Academic Article
|
Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.
|
|
Academic Article
|
Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia.
|
|
Academic Article
|
The effect of changes in head posture on the patterns of muscle activity in cervical dystonia (CD).
|
|
Academic Article
|
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics.
|
|
Academic Article
|
Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia.
|
|
Academic Article
|
Risk factors for progression in Parkinson's disease.
|
|
Academic Article
|
Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
|
|
Academic Article
|
Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing.
|
|
Academic Article
|
"On" freezing in Parkinson's disease: resistance to visual cue walking devices.
|
|
Academic Article
|
Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies.
|
|
Academic Article
|
Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests?
|
|
Academic Article
|
Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.
|
|
Academic Article
|
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.
|
|
Academic Article
|
Bromocriptine-induced myoclonus.
|
|
Academic Article
|
Progressive cognitive decline with truncal/limb ataxia and ballistic movements.
|
|
Academic Article
|
Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia.
|
|
Academic Article
|
Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of the motor scale.
|
|
Academic Article
|
Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS.
|
|
Academic Article
|
Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor.
|
|
Academic Article
|
The malignant course of "benign hallucinations" in Parkinson disease.
|
|
Academic Article
|
Longitudinal outcome of Parkinson's disease patients with psychosis.
|
|
Academic Article
|
Coping strategies for visual hallucinations in Parkinson's disease.
|
|
Academic Article
|
Association study of Parkin gene polymorphisms with idiopathic Parkinson disease.
|
|
Academic Article
|
Wheeled and standard walkers in Parkinson's disease patients with gait freezing.
|
|
Academic Article
|
Impact of placebo assignment in clinical trials of Parkinson's disease.
|
|
Academic Article
|
Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.
|
|
Academic Article
|
Apolipoprotein E controls the risk and age at onset of Parkinson disease.
|
|
Academic Article
|
Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study).
|
|
Academic Article
|
Altered cortical visual processing in PD with hallucinations: an fMRI study.
|
|
Academic Article
|
Short-term and practice effects of metronome pacing in Parkinson's disease patients with gait freezing while in the 'on' state: randomized single blind evaluation.
|
|
Academic Article
|
Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation.
|
|
Academic Article
|
Hallucinations and sleep disorders in PD: six-year prospective longitudinal study.
|
|
Academic Article
|
Transcultural comparison of psychogenic movement disorders.
|
|
Academic Article
|
Rating scale for psychogenic movement disorders: scale development and clinimetric testing.
|
|
Academic Article
|
Thermography - a valuable tool to test hydrocephalus shunt patency.
|
|
Academic Article
|
Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients.
|
|
Academic Article
|
A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations.
|
|
Academic Article
|
Safety of rasagiline in elderly patients with Parkinson disease.
|
|
Academic Article
|
Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms.
|
|
Academic Article
|
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
|
|
Academic Article
|
Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
|
|
Academic Article
|
Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia.
|
|
Academic Article
|
Visual hallucinations and symptoms of REM sleep behavior disorder in Parkinsonian tauopathies.
|
|
Academic Article
|
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.
|
|
Academic Article
|
Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments.
|
|
Academic Article
|
Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long-term worsening.
|
|
Academic Article
|
Comparison of tic characteristics between children and adults.
|
|
Academic Article
|
The Unified Dyskinesia Rating Scale: presentation and clinimetric profile.
|
|
Academic Article
|
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
|
|
Academic Article
|
Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device.
|
|
Academic Article
|
Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
|
|
Academic Article
|
A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.
|
|
Academic Article
|
Fibroblast phenotype in male carriers of FMR1 premutation alleles.
|
|
Academic Article
|
Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease.
|
|
Academic Article
|
A 12-year population-based study of psychosis in Parkinson disease.
|
|
Academic Article
|
Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study.
|
|
Academic Article
|
Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10 years.
|
|
Academic Article
|
Temporal stability of the Unified Dyskinesia Rating Scale.
|
|
Academic Article
|
Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease.
|
|
Academic Article
|
Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale.
|
|
Academic Article
|
Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).
|
|
Academic Article
|
Which dyskinesia scale best detects treatment response?
|
|
Academic Article
|
Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy.
|
|
Academic Article
|
Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale.
|
|
Academic Article
|
The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease.
|
|
Academic Article
|
Vibration therapy for Parkinson's disease: Charcot's studies revisited.
|
|
Academic Article
|
Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.
|
|
Academic Article
|
Continuous in-home monitoring of essential tremor.
|
|
Academic Article
|
Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.
|
|
Academic Article
|
Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.
|
|
Academic Article
|
Handling missing values in the MDS-UPDRS.
|
|
Academic Article
|
Optimized surgical treatment for normal pressure hydrocephalus: comparison between gravitational and differential pressure valves.
|
|
Academic Article
|
Clinimetric testing of the comprehensive cervical dystonia rating scale.
|
|
Academic Article
|
A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease.
|
|
Academic Article
|
Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea.
|
|
Academic Article
|
Levodopa-induced myoclonus.
|
|
Academic Article
|
Ideational fluency in Parkinson's disease.
|
|
Academic Article
|
Adult tics in Gilles de la Tourette's syndrome: description and risk factors.
|
|
Academic Article
|
Blinded evaluation confirms long-term asymmetric effect of unilateral thalamotomy or subthalamotomy on tremor in Parkinson's disease.
|
|
Academic Article
|
Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease.
|
|
Academic Article
|
Effect of MK-458 (HPMC) in Parkinson's disease previously untreated with dopaminergic drugs. A double-blind, placebo-controlled multicenter study.
|
|
Academic Article
|
United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical, and 1- and 2-year follow-up.
|
|
Academic Article
|
Effects of head trauma from motor vehicle accidents on Parkinson's disease.
|
|
Academic Article
|
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group.
|
|
Academic Article
|
Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor data.
|
|
Academic Article
|
Evaluation of a modified inverted walking stick as a treatment for parkinsonian freezing episodes.
|
|
Academic Article
|
Induction of parkinsonism by intraventricular bethanechol in a patient with Alzheimer's disease.
|
|
Academic Article
|
Hypersexuality with antiparkinsonian therapy.
|
|
Academic Article
|
Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa.
|
|
Academic Article
|
Environmental factors and Parkinson's disease: a case-control study in China.
|
|
Academic Article
|
Agonist substitution in advanced Parkinson's disease.
|
|
Academic Article
|
Epidemiology and pathophysiology of tardive dyskinesias.
|
|
Academic Article
|
Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patients.
|
|
Academic Article
|
An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation.
|
|
Academic Article
|
Efficacy of cervical cord stimulation in dystonia.
|
|
Academic Article
|
Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations.
|
|
Academic Article
|
Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods.
|
|
Academic Article
|
The predictive value of acute antimuscarinic drugs for the chronic efficacy of antimuscarinic drugs in adults with focal dystonia.
|
|
Academic Article
|
The adrenal medullary transplant operation for Parkinson's disease: clinical observations in five patients.
|
|
Academic Article
|
Amantadine and motor fluctuations in chronic Parkinson's disease.
|
|
Academic Article
|
Pain in Parkinson's disease.
|
|
Academic Article
|
Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet).
|
|
Academic Article
|
Relationships among pain, depression, and sleep alterations in Parkinson's disease.
|
|
Academic Article
|
Pergolide mesylate: four years experience in Parkinson's disease.
|
|
Academic Article
|
Pergolide mesylate: lack of cardiac toxicity in patients with cardiac disease.
|
|
Academic Article
|
Autonomic dysfunction in Parkinson's disease.
|
|
Academic Article
|
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
|
|
Academic Article
|
Tardive dyskinesia: review and update.
|
|
Academic Article
|
Sinemet skin rash.
|
|
Academic Article
|
Bupropion in Parkinson's disease.
|
|
Academic Article
|
The pharmacology of olivopontocerebellar atrophy.
|
|
Academic Article
|
Fluphenazine and multifocal tic disorders.
|
|
Academic Article
|
Pergolide in Parkinson's disease.
|
|
Academic Article
|
Speech abnormalities in tardive dyskinesia.
|
|
Academic Article
|
Drug holiday in the management of Parkinson disease.
|
|
Academic Article
|
Levodopa-free periods ("drug holidays") in the management of parkinsonism.
|
|
Academic Article
|
Weekly drug holiday in Parkinson disease.
|
|
Academic Article
|
A pure parkinsonian syndrome following acute carbon monoxide intoxication.
|
|
Academic Article
|
Complications of chronic levodopa therapy: long-term efficacy of drug holiday.
|
|
Academic Article
|
Primary writing tremor: a selective action tremor.
|
|
Academic Article
|
Drug-induced asterixis in Parkinson disease.
|
|
Academic Article
|
Mortality and hallucinations in nursing home patients with advanced Parkinson's disease.
|
|
Academic Article
|
Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group.
|
|
Academic Article
|
Talipexole and adult Gilles de la Tourette's syndrome: double-blind, placebo-controlled clinical trial.
|
|
Academic Article
|
Akathisia in Parkinson's disease.
|
|
Academic Article
|
Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures.
|
|
Academic Article
|
Physical therapy and Parkinson's disease: a controlled clinical trial.
|
|
Academic Article
|
Renal complications of infected ventriculoatrial shunts.
|
|
Academic Article
|
[Fetal and adrenal transplantation in Parkinson disease: theoretical bases and clinical results].
|
|
Academic Article
|
Risk factors for nursing home placement in advanced Parkinson's disease.
|
|
Academic Article
|
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuations.
|
|
Academic Article
|
Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exercise.
|
|
Academic Article
|
Prevalence of parkinsonian signs and associated mortality in a community population of older people.
|
|
Academic Article
|
Case 1, 1996: rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma.
|
|
Academic Article
|
Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
|
|
Academic Article
|
Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's disease.
|
|
Academic Article
|
Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels.
|
|
Academic Article
|
Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation.
|
|
Academic Article
|
Neuropsychological deficits in patients with Sneddon's syndrome.
|
|
Academic Article
|
Intact mirror-tracing and impaired rotary-pursuit skill learning in patients with Huntington's disease: evidence for dissociable memory systems in skill learning.
|
|
Academic Article
|
What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study.
|
|
Academic Article
|
What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study.
|
|
Academic Article
|
Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease: two-year follow-up study.
|
|
Academic Article
|
Efficacy of a patient-training videotape on motor fluctuations for on-off diaries in Parkinson's disease.
|
|
Academic Article
|
Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale.
|
|
Academic Article
|
Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations.
|
|
Academic Article
|
Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study.
|
|
Academic Article
|
Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section.
|
|
Academic Article
|
Early dopaminergic drug-induced hallucinations in parkinsonian patients.
|
|
Academic Article
|
Poor visual discrimination and visual hallucinations in Parkinson's disease.
|
|
Academic Article
|
Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease.
|
|
Academic Article
|
Switching dopamine agonists in advanced Parkinson's disease: is rapid titration preferable to slow?
|
|
Academic Article
|
Delayed recognition memory in Parkinson's disease: a role for working memory?
|
|
Academic Article
|
Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off-state.
|
|
Academic Article
|
Parkinson's disease.
|
|
Academic Article
|
Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease.
|
|
Academic Article
|
The alpha-synuclein gene is not a major risk factor in familial Parkinson disease.
|
|
Academic Article
|
Decreased color discrimination and contrast sensitivity in Parkinson's disease.
|
|
Academic Article
|
Objective changes in motor function during placebo treatment in PD.
|
|
Academic Article
|
Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's disease.
|
|
Academic Article
|
[Visual hallucinations in Parkinson and Charles Bonnet Syndrome patients. A phenomenological and pathogenetic comparison].
|
|
Academic Article
|
Differential progression of motor impairment in levodopa-treated Parkinson's disease.
|
|
Academic Article
|
Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients.
|
|
Academic Article
|
Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease.
|
|
Academic Article
|
Visual hallucinations induced by deep brain stimulation in Parkinson's disease.
|
|
Academic Article
|
Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study.
|
|
Academic Article
|
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease.
|
|
Academic Article
|
Ballistic-choreic movements as the presenting feature of renal cancer.
|
|
Academic Article
|
Early morning off-medication dyskinesias, dystonia, and choreic subtypes.
|
|
Academic Article
|
Complete genomic screen in Parkinson disease: evidence for multiple genes.
|
|
Academic Article
|
Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease.
|
|
Academic Article
|
Prospective longitudinal assessment of hallucinations in Parkinson's disease.
|
|
Academic Article
|
Age at onset in two common neurodegenerative diseases is genetically controlled.
|
|
Academic Article
|
Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease.
|
|
Academic Article
|
Progressive worsening of spatial and chromatic processing deficits in Parkinson disease.
|
|
Academic Article
|
Progression of gait, speech and swallowing deficits in progressive supranuclear palsy.
|
|
Academic Article
|
Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.
|
|
Academic Article
|
Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
|
|
Academic Article
|
Tremor and ataxia in fragile X premutation carriers: blinded videotape study.
|
|
Academic Article
|
Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.
|
|
Academic Article
|
Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient.
|
|
Academic Article
|
Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation.
|
|
Academic Article
|
Gender-, age-, and race/ethnicity-based differential item functioning analysis of the movement disorder society-sponsored revision of the Unified Parkinson's disease rating scale.
|
|
Academic Article
|
Differential item functioning in the Unified Dyskinesia Rating Scale (UDysRS).
|
|
Academic Article
|
Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.
|
|
Academic Article
|
Validation study of the hoehn and yahr scale included in the MDS-UPDRS.
|
|
Academic Article
|
Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients.
|
|
Academic Article
|
[Practical assessment of DSAEK in the management of endothelial decompensation following penetrating keratoplasty].
|
|
Academic Article
|
Validation of the MDS clinical diagnostic criteria for Parkinson's disease.
|
|
Academic Article
|
Movement disorder society criteria for clinically established early Parkinson's disease.
|
|
Academic Article
|
Postural Directionality and Head Tremor in Cervical Dystonia.
|
|
Academic Article
|
The Mini-OAKHQOL for knee and hip osteoarthritis quality of life was obtained following recent shortening guidelines.
|
|
Academic Article
|
Validation of the Hebrew Version of the Unified Dyskinesia Rating Scale.
|
|
Academic Article
|
Efficacy, tolerability, and safety of an innovative medical device for improving oral accessibility during oral examination in special-needs patients: A multicentric clinical trial.
|
|
Academic Article
|
COVID-19 Vaccination for Persons with Parkinson's Disease: Light at the End of the Tunnel?
|
|
Academic Article
|
A novel quantitative metric for joint space width: data from the Osteoarthritis Initiative (OAI).
|
|
Academic Article
|
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.
|
|
Academic Article
|
Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers.
|